NICE is updating the way it develops Interventional Procedures guidance to increase the speed and efficiency with which new surgical techniques and other technologies can be safely introduced into the NHS. Amongst the changes is a proposal to more formally recognise the role of device manufacturers in the development of guidance. Under the proposals, medical device manufacturers will now be identified by NICE in the early stages of Interventional Procedure guidance development, if the procedure in question involves a device. Manufacturers will be asked to make a written submission of information about their product to NICE’s Interventional Procedures Advisory Committee, to aid the committee’s discussions.
BMC Cardiovascular Disorders published results of the decision analytic modelling for novel technology to treat mitral regurgitation - "Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings", co-authored by two Synergus researchers.
The Scottish Health Technologies Group (SHTG) is an advisory group set up to provide assistance to NHSScotland when considering non-medicine health technologies. Currently, the SHTG is developing forward work programme and are giving NHS boards in Scotland the opportunity to suggest future topics for assessment. Anyone can refer a topic for consideration, for example NHS boards, clinicians, manufacturers and members of the public. The SHTG provides a range of evidence review products, assessing everything from new innovations to established technologies. The deadline for receiving new topic referrals is 12th of June 2015.
Monitor tracks the performance of NHS foundation trusts to help them prevent operational issues from becoming quality problems and adversely affecting patient care. Issued report summarises the sector’s performance for the year ending 31 March 2015. For the first time, the foundation trust sector (152 bodies) ended the year with a net deficit (before impairments and transfers) of £349m. The size of the deficit was nearly £339m larger than that planned and £475m worse than 2013/14. Monitor is calling for actions: manage staffing cost more efficiently, make cost savings and transform services.
New report of the UK's charity organization in health care focuses of productivity in NHS system with a specific focus on hospitals. Authors predicted overspend of about £626m in 2014/15, despite substantial additional investments from Treasury and investments for capital equipment.
Italian health care budget is composed of regional and national resources. Economic constraints and the willingness to make Regions financially accountable for their planning decisions let the central government implement measures meant to reduce the role of central funding to the sole function of topping-up regional budgets. Read the post by our Market Access Analyst, Cristina Rao, about potential forthcoming changes affecting medical devices and envisaged by the Agreement between Regions and the central government currently under discussion in the Italian politics.
Conferences & Events
CEO Mattias Kyhlstedt will participate and make presentation about Reimbursement of medical devices in Europe.